행동 요법 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global behavioral therapy market size is expected to reach USD 557.10 Billion in 2034 from USD 257.35 Billion in 2025, growing at a CAGR of 8.96 during 2026-2034.This market is witnessing consistent expansion due to the rising prevalence of mental health disorders and increasing awareness regarding psychological well-being. Conditions such as anxiety, depression, and stress-related disorders have become more common due to fast-paced lifestyles, urbanization, and social pressures. Governments and healthcare organizations are actively promoting mental health initiatives, which is encouraging individuals to seek professional therapy. Behavioral therapy, including cognitive behavioral therapy and dialectical behavior therapy, is gaining acceptance as an effective non-pharmacological treatment approach.

Growth is strongly supported by advancements in digital health technologies and teletherapy platforms. Online counseling services have made therapy more accessible, especially in remote or underserved regions. Increasing insurance coverage for mental health services and employer-sponsored wellness programs are also boosting adoption. Additionally, rising investments in mental healthcare infrastructure and training of professionals are helping expand the availability of services. The integration of artificial intelligence and data analytics is further enhancing diagnosis and treatment personalization.

Looking ahead, the market is expected to benefit from continuous innovation in therapy techniques and delivery methods. The adoption of virtual reality-based therapy and mobile mental health applications will further transform the landscape. Emerging economies are likely to experience significant growth due to improving awareness and healthcare access. The long-term outlook remains positive as mental health continues to gain recognition as a critical component of overall well-being.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Disorder Type

• Anxiety Disorders
• Mood Disorders
• Substance Abuse Disorders
• Personality Disorders
• Attention Deficit Disorders

By Application

• Inpatient
• Residential
• Outpatient

COMPANIES PROFILED

• Allergan Inc., Novartis AG, Taro Pharmaceutical Industries Ltd., Perrigo Company plc, Zynerba Pharmaceuticals, Apotex Inc., Sandoz AG, Strides Arcolab Ltd., TOLMAR Pharmaceuticals Inc., Limbix, Allergan Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BEHAVIORAL THERAPY MARKET: BY DISORDER TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disorder Type
• 4.2. Anxiety Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mood Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Substance Abuse Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Personality Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Attention Deficit Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BEHAVIORAL THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Inpatient Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Residential Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Outpatient Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BEHAVIORAL THERAPY MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Disorder Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Disorder Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Disorder Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Disorder Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Disorder Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BEHAVIORAL THERAPY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Allergan Inc
  • 8.2.2 Novartis AG
  • 8.2.3 Taro Pharmaceutical Industries Ltd
  • 8.2.4 Perrigo Company Plc
  • 8.2.5 Zynerba Pharmaceuticals
  • 8.2.6 Apotex Inc
  • 8.2.7 Sandoz AG
  • 8.2.8 Strides Arcolab Ltd
  • 8.2.9 TOLMAR Pharmaceuticals Inc
  • 8.2.10 Limbix
  • 8.2.11 Allergan Inc